NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
25 hedge funds and large institutions have $19.3M invested in NeuBase Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
+3
Holders Change %
+13.64%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
5
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
OrbiMed
New York
|
$2.64M |
| 2 |
Squarepoint
New York
|
$449K |
| 3 |
Renaissance Technologies
New York
|
$2.72M |
| 4 |
PPCM
Pillar Pacific Capital Management
Pacifica,
California
|
$141K |
| 5 |
Jane Street
New York
|
$121K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
JPMorgan Chase & Co
New York
| – | -$99K | -687 | Closed |
|
27
Citadel Advisors
Miami,
Florida
| – | -$85K | -591 | Closed |
|
|
FAIM
28
Financial Advocates Investment Management
Olympia,
Washington
| – | -$72K | -500 | Closed |
|
29
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$38K | -271 | Closed |
|
|
AP
30
Americana Partners
Houston,
Texas
| – | -$1K | -13 | Closed |
|
|
AA
31
Ancora Advisors
Cleveland,
Ohio
| – | -$1K | -5 | Closed |
|